Skip to main content
. 2009 Jun 23;4(3):167–176. doi: 10.1159/000223360

Table 5.

Algorithm for surveillance of cardiac function in patients on trastuzumab (based on Keefe D [91])

LVEF Drop, % Screening interval Trastuzumab
≥ 50% no drop 6 months go
≥ 30% but < 50% > 10 4 weeks go
< 30% > 20 4 weeks stopa
Symptomatic CHF, any LVEF stop

LVEF = left ventricular ejection fraction; CHF = congestive heart failure.

a

Resume trastuzumab when LVEF returns to normal.